Product Program year 2025 Source: CMS Open Payments

VersaCross Steerable Access Solution

Device VersaCross Steerable Access Solution_ICG

PDI 00685447007197

Open in the dashboard

General payments

$34,717

619 payments

Research payments

$0

0 payments

Through program year 2025, $34,717 in general payments and $0 in research payments were reported against VersaCross Steerable Access Solution (VersaCross Steerable Access Solution_ICG).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $9,280 403
2024 General $24,811 191
2023 General $626 25

Breakdown

Who paid General payments · program years 2023–2025
  1. Boston Scientific Corporation $34,717 619 payments
Top recipients General payments · program year 2025
  1. Samual Bass Cardiovascular Disease · Boise, ID $487 5% · 24 payments
  2. Murali Bathina Cardiovascular Disease · Caldwell, ID $487 5% · 24 payments
  3. Shannon McConnaughey Cardiovascular Disease · Meridian, ID $487 5% · 24 payments
  4. Stefanie Fry Cardiovascular Disease · Boise, ID $487 5% · 24 payments
  5. Robert Duerr Interventional Cardiology · Boise, ID $487 5% · 24 payments

The top 5 of 81 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $3,067 33% · 12 practitioners
  2. Interventional Cardiology Internal Medicine $2,107 23% · 21 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $1,807 19% · 13 practitioners
  4. Physician Assistant $463 5% · 5 practitioners
  5. Anesthesiology $361 4% · 6 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Idaho $5,335 57% · 13 recipients
  2. Washington $590 6% · 5 recipients
  3. Oregon $580 6% · 8 recipients
  4. Montana $512 6% · 4 recipients
  5. Colorado $452 5% · 1 recipient

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

619 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record